Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-11-27EMA Lapsed: Celdoxome pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.
EMA notes that the marketing authorization for Celdoxome pegylated liposomal doxorubicin hydrochloride has lapsed, covering breast cancer, o…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer [Phase 3]
Phase 3 trial update reports substantially improved cure rates for high-risk BRCA1-like breast cancer.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases [NA]
This clinical trial update describes an ongoing study evaluating standard treatment with or without SBRT for solid tumors that have 1 to 5 b…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection [NA]
This document reports the completion and posted results of a pilot clinical evaluation of a microwave imaging system for breast cancer detec…
-
CLINICAL_TRIALS withdrawal · 2025-11-26Clinical Trial Update: The Impact of Intraoperative Methadone on Postoperative Opioid Use [Phase 3]
A Phase 3 trial evaluating intraoperative methadone to reduce postoperative opioid use in breast cancer patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Molecular and Cellular Analysis of Breast Cancer
The Stanford-sponsored trial focusing on molecular and cellular analyses of breast cancer has completed.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of YL202 in Selected Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study of YL202 in selected patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and head and nec…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients [NA]
A recruiting clinical study at The Netherlands Cancer Institute is examining how chemosensitivity in breast cancer patients varies across ph…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Motiva Flora® Aesthetic Breast Recon® Clinical Study [NA]
The Motiva Flora Aesthetic Breast Recon trial (NCT06146231) is currently recruiting to evaluate reconstruction options for patients undergoi…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a carcinoembryonic antigen (CEA)-targeted CAR-T therapy in patients with CEA-positive advanced solid tumors, inc…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: SAVE Trial: SAfe Opioid Use Video Education [NA]
Clinical trial update for the SAVE Trial on safe opioid use video education for patients undergoing breast reconstruction due to breast canc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing EC-T versus PCb as adjuvant chemotherapy for non-triple-negative breast cancer; the study is currently ac…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial update on the Triple-B study comparing carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumab as…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients [Phase 4]
A Phase 4 clinical trial compares AI-assisted screening mammography to standard screening without AI to evaluate cancer detection and recall…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Basket Study for Oligo-metastatic Breast Cancer [Phase 2]
Phase 2 basket trial evaluating therapies for oligo-metastatic HER2-positive breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
A clinical trial evaluating combined low-pass whole-genome sequencing and methylome testing of bloody nipple discharge to differentiate beni…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer [Phase 2]
A Phase 2 trial is investigating whether pegfilgrastim affects trastuzumab’s anti-tumor activity and ADCC in operable HER2-positive breast c…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
An ongoing real-world study evaluating a Trop-2–targeting antibody-drug conjugate in breast cancer patients with brain metastases, sponsored…
-
EMA approval · 2025-11-25EMA Authorised: Tukysa (tucatinib) — Pfizer Europe MA EEIG
The EMA has authorised Tukysa (tucatinib) for use in the European Union for metastatic breast cancer, with Pfizer Europe MA EEIG as the mark…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Erector Spinae Plane Block Versus Local Wound Infiltration After Modified Radical Mastectomy [NA]
This completed clinical trial compared erector spinae plane (ESP) block to local wound infiltration for postoperative pain management after …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating a PEG-G-CSF injection to prevent chemotherapy-induced neutropenia, with status listed as active but not re…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA [Phase 1, Phase 2]
The document provides a clinical trial update on QUILT-3.038, a Phase 1/2 active immunotherapy vaccine targeting carcinoembryonic antigen (C…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers [Phase 1]
Phase 1 clinical trial evaluating hypofractionated radiotherapy in combination with durvalumab (MEDI4736) and tremelimumab in patients with …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB) [NA]
Clinical trial update for the CHiB study evaluating a Confocal Histolog Scanner used in routine breast-conserving surgery. The trial is curr…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
This clinical trial update describes a real-world study of palbociclib use and its effects in US patients with breast cancer. The study is s…